137 related articles for article (PubMed ID: 10673371)
1. Human membrane type-2 matrix metalloproteinase is defective in cell-associated activation of progelatinase A.
Miyamori H; Takino T; Seiki M; Sato H
Biochem Biophys Res Commun; 2000 Jan; 267(3):796-800. PubMed ID: 10673371
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors.
Llano E; Pendás AM; Freije JP; Nakano A; Knäuper V; Murphy G; López-Otin C
Cancer Res; 1999 Jun; 59(11):2570-6. PubMed ID: 10363975
[TBL] [Abstract][Full Text] [Related]
3. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.
Velasco G; Cal S; Merlos-Suárez A; Ferrando AA; Alvarez S; Nakano A; Arribas J; López-Otín C
Cancer Res; 2000 Feb; 60(4):877-82. PubMed ID: 10706098
[TBL] [Abstract][Full Text] [Related]
4. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
[TBL] [Abstract][Full Text] [Related]
5. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.
Sato H; Okada Y; Seiki M
Thromb Haemost; 1997 Jul; 78(1):497-500. PubMed ID: 9198203
[TBL] [Abstract][Full Text] [Related]
6. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
7. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
Itoh Y; Takamura A; Ito N; Maru Y; Sato H; Suenaga N; Aoki T; Seiki M
EMBO J; 2001 Sep; 20(17):4782-93. PubMed ID: 11532942
[TBL] [Abstract][Full Text] [Related]
8. Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes.
Nakada M; Yamada A; Takino T; Miyamori H; Takahashi T; Yamashita J; Sato H
Cancer Res; 2001 Dec; 61(24):8896-902. PubMed ID: 11751414
[TBL] [Abstract][Full Text] [Related]
9. Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate: a protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase.
Foda HD; George S; Conner C; Drews M; Tompkins DC; Zucker S
Lab Invest; 1996 Feb; 74(2):538-45. PubMed ID: 8780171
[TBL] [Abstract][Full Text] [Related]
10. The 9-kDa N-terminal propeptide domain of MT1-MMP is required for the activation of progelatinase A.
Cao J; Drews M; Lee HM; Conner C; Bahou WF; Zucker S
Ann N Y Acad Sci; 1999 Jun; 878():710-2. PubMed ID: 10415815
[No Abstract] [Full Text] [Related]
11. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond.
Nie J; Pei D
Cancer Res; 2003 Oct; 63(20):6758-62. PubMed ID: 14583471
[TBL] [Abstract][Full Text] [Related]
12. Activation of progelatinase A and progelatinase A/TIMP-2 complex by membrane type 2-matrix metalloproteinase.
Kolkenbrock H; Hecker-Kia A; Orgel D; Ulbrich N; Will H
Biol Chem; 1997 Feb; 378(2):71-6. PubMed ID: 9088534
[TBL] [Abstract][Full Text] [Related]
13. Messenger RNA for membrane-type 2 matrix metalloproteinase, MT2-MMP, is expressed in human placenta of first trimester.
Bjørn SF; Hastrup N; Larsen JF; Lund LR; Pyke C
Placenta; 2000; 21(2-3):170-6. PubMed ID: 10736239
[TBL] [Abstract][Full Text] [Related]
14. Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase.
Kinoshita T; Sato H; Takino T; Itoh M; Akizawa T; Seiki M
Cancer Res; 1996 Jun; 56(11):2535-8. PubMed ID: 8653693
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of MT3-MMP in transfected MDCK cells: progelatinase A activation and tubulogenesis in 3-D collagen lattice.
Kang T; Yi J; Yang W; Wang X; Jiang A; Pei D
FASEB J; 2000 Dec; 14(15):2559-68. PubMed ID: 11099475
[TBL] [Abstract][Full Text] [Related]
16. Isolation of a mouse MT2-MMP gene from a lung cDNA library and identification of its product.
Tanaka M; Sato H; Takino T; Iwata K; Inoue M; Seiki M
FEBS Lett; 1997 Feb; 402(2-3):219-22. PubMed ID: 9037199
[TBL] [Abstract][Full Text] [Related]
17. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP).
Sato H; Takino T; Kinoshita T; Imai K; Okada Y; Stetler Stevenson WG; Seiki M
FEBS Lett; 1996 May; 385(3):238-40. PubMed ID: 8647259
[TBL] [Abstract][Full Text] [Related]
18. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
[TBL] [Abstract][Full Text] [Related]
19. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
Monea S; Lehti K; Keski-Oja J; Mignatti P
J Cell Physiol; 2002 Aug; 192(2):160-70. PubMed ID: 12115722
[TBL] [Abstract][Full Text] [Related]
20. Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase.
Chen JM; Fortunato M; Stevens RA; Barrett AJ
Biol Chem; 2001 May; 382(5):777-83. PubMed ID: 11517930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
